未登录The first-in-class PRX3 inhibitor RSO-021 modulates the composition of malignant pleural effusions by eliciting immunomodulation and decreasing epithelial to mesenchymal protein expression第一类PRX3抑制剂RSO-021通过引发免疫调节并降低上皮-间质蛋白表达,来调节恶性胸腔积液的组成。
Messier, Terri; Cech, Bradley; Dzialo, Joanna; Gibson, Victoria; Poile, Charlotte; Nakas, Apostolos; Kutywayo, Kudzayi; Bzura, Aleksandra; Rogel, Jan; Naumov, George; Landry, Christopher; Fennell, Dean; Cunniff, Brian
分享
收藏
分享
收藏